103 related articles for article (PubMed ID: 15475654)
1. Effect of the long-term treatment with trandolapril on endoglin expression in rats with experimental renal fibrosis induced by renal mass reduction.
Prieto M; Rodríguez-Peña A; Arévalo M; Rivas JV; Düwel A; Eleno N; Sánchez RJ; Morales AI; López-Novoa JM; Pérez-Barriocanal F
Kidney Blood Press Res; 2005; 28(1):32-40. PubMed ID: 15475654
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction.
Rodríguez-Peña A; Prieto M; Duwel A; Rivas JV; Eleno N; Pérez-Barriocanal F; Arévalo M; Smith JD; Vary CP; Bernabeu C; López-Novoa JM
Nephrol Dial Transplant; 2001; 16 Suppl 1():34-9. PubMed ID: 11369818
[TBL] [Abstract][Full Text] [Related]
3. Temporal changes in renal endoglin and TGF-beta1 expression following ureteral obstruction in rats.
Prieto M; Rodríguez-Peña AB; Düwel A; Rivas JV; Docherty N; Pérez-Barriocanal F; Arévalo M; Vary CP; Bernabeu C; López-Novoa JM; Eleno N
J Physiol Biochem; 2005 Sep; 61(3):457-67. PubMed ID: 16440600
[TBL] [Abstract][Full Text] [Related]
4. Endoglin upregulation during experimental renal interstitial fibrosis in mice.
Rodríguez-Peña A; Eleno N; Düwell A; Arévalo M; Pérez-Barriocanal F; Flores O; Docherty N; Bernabeu C; Letarte M; López-Novoa JM
Hypertension; 2002 Nov; 40(5):713-20. PubMed ID: 12411467
[TBL] [Abstract][Full Text] [Related]
5. L-Arginine treatment may prevent tubulointerstitial nephropathy caused by germanium dioxide.
Yanagisawa H; Yamazaki N; Sato G; Wada O
Kidney Int; 2000 Jun; 57(6):2275-84. PubMed ID: 10844598
[TBL] [Abstract][Full Text] [Related]
6. [Effect of perindopril on renal interstitial fibrosis of hypertension in rats].
Xu H; Tao LJ; Sun M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):61-4. PubMed ID: 16137008
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of alpha-smooth muscle actin and transforming growth factor-beta1.
Wang HY; Wang YJ; Cui MJ; Gu CM; Yang LZ; Zhao Y; Chen Y; Zhao D; Li TS; Chi BR
Indian J Biochem Biophys; 2011 Oct; 48(5):308-15. PubMed ID: 22165288
[TBL] [Abstract][Full Text] [Related]
8. Rutin ameliorates renal fibrosis and proteinuria in 5/6-nephrectomized rats by anti-oxidation and inhibiting activation of TGFβ1-smad signaling.
Han Y; Lu JS; Xu Y; Zhang L; Hong BF
Int J Clin Exp Pathol; 2015; 8(5):4725-34. PubMed ID: 26191162
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of the long-term treatment with the combination of an ACE inhibitor and a calcium channel blocker on renal injury in rats with 5/6 nephrectomy.
Flores O; Arévalo M; Gallego B; Hidalgo F; Vidal S; López-Novoa JM
Exp Nephrol; 1998; 6(1):39-49. PubMed ID: 9523172
[TBL] [Abstract][Full Text] [Related]
10. You-gui Pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-β/Smad signaling pathway.
Wang L; Cao AL; Chi YF; Ju ZC; Yin PH; Zhang XM; Peng W
J Ethnopharmacol; 2015 Jul; 169():229-38. PubMed ID: 25922264
[TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.
Gilbert RE; Cox A; Wu LL; Allen TJ; Hulthen UL; Jerums G; Cooper ME
Diabetes; 1998 Mar; 47(3):414-22. PubMed ID: 9519748
[TBL] [Abstract][Full Text] [Related]
12. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
13. Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy.
Shihab FS; Andoh TF; Tanner AM; Bennett WM
Am J Kidney Dis; 1997 Jul; 30(1):71-81. PubMed ID: 9214404
[TBL] [Abstract][Full Text] [Related]
14. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
15. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
17. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis.
Morrissey JJ; Ishidoya S; McCracken R; Klahr S
Kidney Int Suppl; 1996 May; 54():S83-7. PubMed ID: 8731201
[TBL] [Abstract][Full Text] [Related]
18. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 upregulation is independent of angiotensin in paraquat-induced lung fibrosis.
Chen CM; Chou HC; Hsu HH; Wang LF
Toxicology; 2005 Dec; 216(2-3):181-7. PubMed ID: 16182431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
